Literature DB >> 9704912

NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.

S Morel1, E Terreno, E Ugazio, S Aime, M R Gasco.   

Abstract

This work deals with the preparation and relaxometric investigations of solid lipid nanoparticles (SLN) containing [Gd-DTPA(H2O)]2- and [Gd-DOTA(H2O)]-. These paramagnetic chelates are commonly used as contrast agents (CA) for magnetic resonance imaging (MRI) owing to their ability to strongly increase the tissue water proton relaxation rate. The amount of gadolinium(III) (Gd(III)) complex included in the SLN has been evaluated and, on this basis, it has been found that the longitudinal relaxivity of these Gd(III) chelates apparently does not vary, at physiological pH, following their inclusion in SLN. We are unable to establish whether this is due to the free exchange of water from the inner compartment containing the Gd(III) chelate to the bulk water or whether the observed relaxation rate is essentially determined by a fraction of the complex which is close to the surface of the SLN in a region easily accessible to the bulk water. At acidic pH values, the relaxivity of the paramagnetic SLN containing the less thermodynamically and kinetically stable [Gd-DTPA(H2O)]2- markedly increases. This effect may be ascribed to an increased immobilization and/or to an enhanced hydration of the complex on SLN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704912     DOI: 10.1016/s0939-6411(97)00107-0

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

1.  Lectin conjugates as biospecific contrast agents for MRI. Coupling of Lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers.

Authors:  Irena Pashkunova-Martic; Christian Kremser; Markus Galanski; Petra Schluga; Vladimir Arion; Paul Debbage; Werner Jaschke; Bernhard Keppler
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

2.  Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.

Authors:  Erica Andreozzi; Jai Woong Seo; Katherine Ferrara; Angelique Louie
Journal:  Bioconjug Chem       Date:  2011-03-09       Impact factor: 4.774

3.  Development of nanoparticle-based magnetic resonance colonography.

Authors:  Jihong Sun; Weiliang Zheng; Hui Zhang; Tao Wu; Hong Yuan; Xiaoming Yang; Shizheng Zhang
Journal:  Magn Reson Med       Date:  2010-11-03       Impact factor: 4.668

Review 4.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

5.  Solid lipid nanoparticles: a modern formulation approach in drug delivery system.

Authors:  S Mukherjee; S Ray; R S Thakur
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

6.  Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation.

Authors:  Xue Dong; Jingfeng Luo; Pengxun Lan; Xiuyu Guo; Xin Zhao; Xiaoyan Wang; Fei Zhou; Qiangfeng Wang; Hong Yuan; Jihong Sun
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

Review 7.  Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.

Authors:  Sabrina Valetti; Simona Mura; Barbara Stella; Patrick Couvreur
Journal:  J Nanobiotechnology       Date:  2013-12-10       Impact factor: 10.435

Review 8.  Lipid-drug conjugates: a potential nanocarrier system for oral drug delivery applications.

Authors:  Subham Banerjee; Amit Kundu
Journal:  Daru       Date:  2018-08-04       Impact factor: 3.117

9.  Lipid-based nanoparticles in cancer diagnosis and therapy.

Authors:  Andrew D Miller
Journal:  J Drug Deliv       Date:  2013-07-09

Review 10.  Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.

Authors:  Rajamani Lakshminarayanan; Enyi Ye; David James Young; Zibiao Li; Xian Jun Loh
Journal:  Adv Healthc Mater       Date:  2018-05-02       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.